Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical

Milind Y Desai1, Alaa Alashi1, Zoran B Popovic1

  • 1Hypertrophic Cardiomyopathy and Valve Center Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Insights

Patients with severe obstructive hypertrophic cardiomyopathy (HCM) and aortic stenosis undergoing combined surgery had lower-than-expected mortality. Longer-term survival was similar to the general population, with age and kidney disease impacting outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Cardiac Surgery Outcomes

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) and aortic stenosis (AS) impede left ventricular outflow tract (LVOT) blood flow.
  • Obstructive HCM causes dynamic LVOT obstruction; AS causes fixed obstruction due to calcific degeneration.
  • Combined severe obstructive HCM and moderate/severe AS necessitates surgical intervention.

Purpose of the Study:

  • To characterize patients with severe obstructive HCM and concomitant moderate/severe AS.
  • To report longer-term outcomes following combined surgical myectomy and aortic valve replacement (AVR).

Main Methods:

  • Retrospective study of 191 consecutive patients undergoing myectomy and AVR (June 2002-June 2018).
  • Data collected: clinical characteristics, echocardiography (LVOT gradient, indexed AV area).
  • Primary outcome: all-cause mortality; survival analysis performed.

Main Results:

  • High prevalence of hypertension (63%) and hyperlipidemia (75%); Society of Thoracic Surgeons score: 5±4.
  • All patients had dynamic LVOT gradient >50 mm Hg; mean basal septal thickness: 1.9±0.4 cm.
  • At 6.5±4 years follow-up, 27% died; 1-, 2-, and 5-year survival rates were 94%, 91%, and 83% respectively, similar to age-sex-matched general population.

Conclusions:

  • Combined surgical myectomy and AVR in severe obstructive HCM with AS yielded significantly lower postoperative mortality than expected.
  • Longer-term survival post-combined surgery was comparable to the general US population.
  • Age, chronic kidney disease, and elevated right ventricular systolic pressure were associated with mortality; traditional HCM risk factors were not.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
59
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
46
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
77
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
74
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96